SCHEMBL2178982

SCHEMBL2178982

COCNC(=O)c1ncnn1Cc1c(-c2ccc(Cl)cc2)nc2ccc(Cl)cn12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSPO P30536 2/20 0.46
▸ NR1I2 O75469 1/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ ALB P02768 1/20 0.46
▸ ADORA3 P0DMS8 1/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ OPRM1 P35372 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ OPRK1 P41145 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ SLC2A1 P11166 7/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ GABRA2 P47869 1/20 0.45
▸ GABRB2 P47870 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2225808 0.88 SLC2A1 (0.49) TSPONR1I2ABCB11ALBADORA3
SCHEMBL2180865 0.88 SLC2A1 (0.49) TSPONR1I2ABCB11ALBADORA3
SCHEMBL4324580 0.83 SLC2A1 (0.53) TSPONR1I2ABCB11ALBADORA3
SCHEMBL1429966 0.83 ALDH1A1 (0.52) TSPONR1I2ABCB11ALBADORA3
SCHEMBL2197080 0.83 SLC2A1 (0.52) TSPONR1I2ABCB11ALBADORA3
SCHEMBL1432945 0.82 SLC2A1 (0.56) TSPONR1I2ABCB11ALBADORA3
SCHEMBL2179254 0.82 CYP1A2 (0.52) SLC2A1ALDH1A1GABRA2GABRB2GAA
SCHEMBL2196283 0.82 ALDH1A1 (0.55) TSPONR1I2ABCB11ALBADORA3
SCHEMBL2178544 0.81 ALDH1A1 (0.49) TSPONR1I2ABCB11ALBADORA3
SCHEMBL2202779 0.77 KDM4E (0.51) SLC2A1GABRB2KDM4EHTTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. 2013-10-31 — — US disclosed
US-8497278-B2 Imidazo[1,2-a]pyridine compounds SUNOVION PHARMACEUTICALS INC. (US) 2013-07-30 — — US disclosed
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS SUNOVION PHARMACEUTICALS INC. (US) 2011-07-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166146-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD TSPO 1694/4885NR1I2 498/4885ABCB11 126/4885
US-20130289013-A1 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS PAICS, ITPA, DPYD TSPO 1694/4885NR1I2 498/4885ABCB11 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback